Becton Dickinson and Co (BDX):企業財務及び戦略的SWOT分析

【英語タイトル】Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(GDME511FSA)・商品コード:GDME511FSA
・発行会社(調査会社):GlobalData
・発行日:2017年2月1日
・ページ数:74
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥14,125見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥42,375見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Becton Dickinson and Co (BDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infectionsand cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

Jan 26, 2017: New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes Through Collaboration
Jan 17, 2017: BD Launches Reagents to Simplify Single Cell Research
Dec 05, 2016: BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit’s Opinion
Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Becton Dickinson and Co – Key Facts 6
Becton Dickinson and Co – Key Employees 7
Becton Dickinson and Co – Key Employee Biographies 9
Becton Dickinson and Co – Major Products and Services 10
Becton Dickinson and Co – Medical Equipment Pipeline Products Data 13
Becton Dickinson and Co Pipeline Products by Equipment Type 13
Becton Dickinson and Co Pipeline Products by Development Stage 14
Becton Dickinson and Co – History 17
Becton Dickinson and Co – Company Statement 29
Becton Dickinson and Co – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Section 2 – Company Analysis 38
Becton Dickinson and Co – Business Description 38
Business Description – BD Life Sciences 38
BD Life Sciences – Overview 38
BD Life Sciences – Financials 38
BD Life Sciences – Capital Expenditure 38
Business Description – BD Medical 39
BD Medical – Overview 39
BD Medical – Financials 39
BD Medical – Capital Expenditure 39
Becton Dickinson and Co – Corporate Strategy 40
Becton Dickinson and Co – SWOT Analysis 41
SWOT Analysis – Overview 41
Becton Dickinson and Co – Strengths 41
Becton Dickinson and Co – Weaknesses 43
Becton Dickinson and Co – Opportunities 44
Becton Dickinson and Co – Threats 46
Becton Dickinson and Co – Key Competitors 47
Section 3 – Company Financial Ratios 48
Financial Ratios – Capital Market Ratios 48
Financial Ratios – Annual Ratios 49
Performance Chart 51
Financial Performance 51
Financial Ratios – Interim Ratios 52
Financial Ratios – Ratio Charts 53
Section 4 – Company’s Lifesciences Financial Deals and Alliances 54
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 54
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2011 to YTD 2017 55
Becton Dickinson and Co, Recent Deals Summary 56
Section 5 – Company’s Recent Developments 57
Dec 05, 2016: BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management 57
Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit’s Opinion 58
Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 59
Sep 22, 2016: BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing 61
Sep 12, 2016: BD Announces New Software Release for Pyxis Enterprise Solution 62
Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 63
Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 65
Jun 06, 2016: B. Braun Medical and Affiliates Sue Becton, Dickinson for IV Catheter Safety Mechanism Patent Infringements 66
May 26, 2016: BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody System 67
May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter 68
Section 6 – Appendix 70
Methodology 70
Ratio Definitions 70
About GlobalData 74
Contact Us 74
Disclaimer 74

List of Tables
Becton Dickinson and Co, Key Facts 6
Becton Dickinson and Co, Key Employees 7
Becton Dickinson and Co, Key Employee Biographies 9
Becton Dickinson and Co, Major Products and Services 10
Becton Dickinson and Co Pipeline Products by Equipment Type 13
Becton Dickinson and Co Number of Pipeline Products by Development Stage 14
Becton Dickinson and Co Pipeline Products Summary by Development Stage 15
Becton Dickinson and Co, History 17
Becton Dickinson and Co, Other Locations 31
Becton Dickinson and Co, Subsidiaries 32
Becton Dickinson and Co, Key Competitors 47
Becton Dickinson and Co, Ratios based on current share price 48
Becton Dickinson and Co, Annual Ratios 49
Becton Dickinson and Co (Cont...1), Annual Ratios 50
Becton Dickinson and Co, Interim Ratios 52
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 54
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2011 to YTD 2017 55
Becton Dickinson and Co, Recent Deals Summary 56
Currency Codes 70
Capital Market Ratios 70
Equity Ratios 71
Profitability Ratios 71
Cost Ratios 72
Liquidity Ratios 72
Leverage Ratios 72
Efficiency Ratios 73

List of Figures
Becton Dickinson and Co Pipeline Products by Equipment Type 13
Becton Dickinson and Co Pipeline Products by Development Stage 14
Becton Dickinson and Co, Performance Chart (2012 - 2016) 51
Becton Dickinson and Co, Ratio Charts 53
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 54
Becton Dickinson and Co, Medical Equipment, Deals by Type, 2011 to YTD 2017 55

★調査レポート[Becton Dickinson and Co (BDX):企業財務及び戦略的SWOT分析] (コード:GDME511FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Becton Dickinson and Co (BDX):企業財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆